Personalized screening for cancers: Should we consider polygenic profiling?

Personalized Medicine

Volumn 10, Issue 6, 2013, Pages 511-513

  Pashayan, Nora ^a   Guo, Qi ^b   Pharoah, Paul Dp ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

cancer; personalized screening; polygenic profiling

Indexed keywords

BREAST CANCER; CANCER SCREENING; GENE EXPRESSION PROFILING; GENETIC SUSCEPTIBILITY; GENOMICS; HUMAN; OVARY CANCER; PERSONALIZED MEDICINE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

EID: 84881395338     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/pme.13.46     Document Type: Review

References (16)

1. Burton H, Sagoo GS, Pharoah P, Zimmern RL. Time to revisit Geoffrey Rose: Strategies for prevention in the genomic era? Ital. J. Public Health 9(4), e8665 (2012
2. Pharoah PD, Antoniou AC, Easton DF, Ponder BA. Polygenes, risk prediction, and targeted prevention of breast cancer. N. Engl. J. Med. 358(26), 2796-2803 (2008
3. Pashayan N, Duffy SW, Chowdhury S et al. Polygenic susceptibility to prostate and breast cancer: Implications for personalised screening. Br. J. Cancer 104(10), 1656-1663 (2011
4. Bahcall OG. iCOGS collection provides a collaborative model. Foreword. Nat. Genet. 45(4), 343 (2013
5. Michailidou K, Hall P, Gonzalez-Neira A et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat. Genet. 45(4), 353-361 (2013
6. Pharoah PD, Tsai YY, Ramus SJ et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat. Genet. 45(4), 362-362 (2013
7. Eeles RA, Olama AA, Benlloch S et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat. Genet. 45(4), 385-391 (2013
8. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA. Polygenic susceptibility to breast cancer and implications for prevention. Nat. Genet. 31(1), 33-36 (2002
9. van Zitteren M, Van Der Net JB, Kundu S, Freedman AN, Van Duijn CM, Janssens AC. Genome-based prediction of breast cancer risk in the general population: A modeling study based on meta-analyses of genetic associations. Cancer Epidemiol. Biomarkers Prev. 20(1), 9-22 (2011
10. Risk prediction and population screening for breast, ovarian and prostate cancers. Nat. Genet. doi:10.1038/ngicogs.5 (2013) (Epub ahead of print
11. Breast Cancer Linkage Consortium: Cancer risks in BRCA2 mutation carriers. The breast cancer linkage consortium. J. Natl Cancer Inst. 91, 1310-1316 (1999
12. Pashayan N, Pharoah P. Translating genomics into improved population screening: Hype or hope? Hum. Genet. 130(1), 19-21 (2011
13. Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P. Public health implications from COGS and potential for risk stratification and screening. Nat. Genet. 45(4), 349-351 (2013
14. Dent T, Jbilou J, Rafi I et al. Stratified cancer screening: The practicalities of implementation. Public Health Genomics 16(3), 94-99 (2013
15. Chowdhury S, Dent T, Pashayan N et al. Incorporating genomics into breast and prostate cancer screening: Assessing the implications. Genet. Med. 15(6), 423-432 (2013
16. Goddard KA, Knaus WA, Whitlock E et al. Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research. Genet. Med. 14(7), 633-642 (2012